Skip to content

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Learn more

Image conveying subsequent treatment options for relapsed Neuroendocrine Tumors (NET).

Subsequent treatment options

Many different therapeutic options are available for patients with NETs, so it is normal to receive several treatments during your NET journey2. Once disease progression has been identified, the aim of subsequent treatments is to slow the progression as much as possible and control new symptoms. Your treatment plan may include a combination of different types of available treatments.

Follow-up after treatment Back to overview
You’re now leaving the website myNETjourney.com
This link is provided for information purposes only. Please be aware that, if you click on it, you will leave myNETjourney.com website. The link will take you to a website owned and operated by an independent party over which ITM Oncologics GmbH has no control or influence (“third-party website”).
ITM Oncologics GmbH makes no representation that information on the third-party website is appropriate or available for use or access in locations outside the country for which the third-party website is intended. Therefore, ITM Oncologics GmbH declines any responsibility for third-party information. ITM Oncologics GmbH makes no representation regarding the data usage policies of the third party website and declines any responsibility for the use of personal data by the operator of the third-party website. Please ensure that you belong to the intended audience of the content provided on third-party website and that your access to it complies with the applicable laws and regulations.
 
Do you really want to leave the myNETjourney.com website?
Welcome to myNETjourney.com
In order to provide you with information tailored to your needs, we kindly ask you to select one of the following: